Your search for nanoviricides returned 7 results

NanoViricides Raises $9.9M at 26% Discount

NanoViricides, Inc. (NNVCD) announced that it has raised $9,985,500 in a Registered Direct transaction. The common stock was sold at $3.50 per share, an approximate 26% discount to the market price ($4.76) of NNVCD at deal announcement. A series of 2,853,000 60-Month Warrants with an exercise price of $5.25 per share (10.29% premium) was issued to the investors in this transaction. Chardan Capital Markets and Midtown Partners acted as agents on the transaction. The transaction is expected to close by 09/13/2013.

Source: PlacementTracker

Posted on: September 11, 2013

NanoViricides Raises $6M in Conv Debt at 108% Premium

NanoViricides, Inc. (NNVC) announced that it has raised $6,000,000 in a Convertible Unsecured Debentures transaction. The fixed conversion price of the Convertible Unsecured Debentures is $1.00 per share, an approximate 108.25% premium to the market price ($0.48) of NNVC at deal announcement. The Company shall pay interest of 8% per annum plus additional interest upon Closing and each anniversary of the Closing.

Source: PlacementTracker

Posted on: February 1, 2013